Psychedelic drug trials face a fundamental credibility problem because participants almost always know they've received the active drug, making it nearly impossible to separate genuine therapeutic effects from the power of expectation and belief.
Psychedelic drug trials face a fundamental credibility problem because participants almost always know they've received the active drug, making it nearly impossible to separate genuine therapeutic effects from the power of expectation and belief.